CardioVascular BioTherapeutics (fka CVBT)

[KalratiInvestor]

I bought into the $3 offering. I met the CEO in Singapore earlier this year. A good straightforward guy and the largest shareholder in CVBT.
I originally purchased CVBT on the OTCBB years ago and had an average price of just over 30 cents per share. I subscribed for a further 33,334 shares a couple of months ago. I have to correct your negative worth assertion. CVBT has reorganised the balance sheet by drastically smashing the debt onboard. The progress on the patent portfolio is impressive. IP is what drives value in biotech.